IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Astec Lifesciences

NSE:ASTEC · ISIN INE563J01010

Close
₹642.65
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Astec Lifesciences

Ratings & risks

Credit signals

Rating-action history

Agency evidence
ICRA Limited · Astec LifeSciences Limited: Ratings reaffirmedICRA Limited · PDF preserved by IndiaTicker
Archived PDF
ICRA Limited · Astec LifeSciences Limited: Ratings reaffirmed; [ICRA]AA-(Negative) assigned for Non Convertible DebenturesICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Ratings reaffirmed; outlook revised to Negative from StableICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Change of limitsICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Update on material eventICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Ratings reaffirmed; outlook revised to Stable from Positive; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Ratings reaffirmed; outlook revised to Positive from Stable; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Rating reaffirmed for Commercial Paper, rated amount enhanced; [ICRA]A1+ assigned to the enhanced Commercial Paper limitsICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Ratings reaffirmed; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Ratings reaffirmed; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited - Update on Material EventICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Update on Material EventICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Long-term rating upgraded to [ICRA]AA-; short-term rating reaffirmed; CP amount enhanced; rating removed from watch with positive implications; Stable outlook assignedICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Long-term rating placed on watch with positive implicationsICRA Limited · discovered
Agency source
ICRA Limited · Astec LifeSciences Limited: Ratings upgraded to [ICRA]A+(Stable)/[ICRA]A1+; rated amount enhancedICRA Limited · discovered
Agency source
ICRA Limited · ICRA assigns short-term rating of [ICRA]A1 to the commercial paper programme of Astec LifeSciences LimitedICRA Limited · discovered
Agency source
ICRA Limited · ICRA upgrades the ratings for the bank facilities of Astec LifeSciences Limited to [ICRA]A (Stable) / [ICRA]A1ICRA Limited · discovered
Agency source
ICRA Limited · ICRA assigned ratings of [ICRA]A-(stable) and [ICRA]A2+ for enhanced bank facilities of Astec LifeSciences LimitedICRA Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium